Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The Novel High-Risk Multiple Myeloma IMS/IMWG Criteria Identify Previously Overlooked Newly-Diagnosed Patients with Poor Prognosis: Validation and Real-World Application — Charalampos Filippatos (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Novel High-Risk Multiple Myeloma IMS/IMWG Criteria Identify Previously Overlooked Newly-Diagnosed Patients with Poor Prognosis: Validation and Real-World Application
Shared by
Meletios A Dimopoulos
The Novel High-Risk Multiple Myeloma IMS/IMWG Criteria Identify Previously Overlooked Newly-Diagnosed Patients with Poor Prognosis: Validation and Real-World Application
Article
2025
en
Authors
+11 more
CF
Charalampos Filippatos
IN
Ioannis Ntanasis-Stathopoulos
PM
Panagiotis Malandrakis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Increased Levels of Circulating Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma Are Independently Associated with Poor Prognosis
Ioannis V. Kostopoulos
,
Panagiotis Malandrakis
,
Ioannis Ntanasis‐Stathopoulos
,
Pantelis Roussakis
,
Evangelos Eleutherakis Papaiakovou
,
Chrysanthi Panteli
,
Nikolaos Angelis
,
Nikolaos Kanellias
,
Nikolaos Orologas‐Stavrou
,
Foteini Theodorakakou
,
Despina Fotiou
,
Magdalini Migkou
,
Maria Gavriatopoulou
,
Efstathios Kastritis
,
Ourania Tsitsilonis
,
Meletios A Dimopoulos
,
Evangelos Terpos
Article
2025
Validation of the new ims/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients
Efstathios Kastritis
,
Maria Gavriatopoulou
,
Foteini Theodorakakou
,
Eirini Solia
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Nikolaos Kanellias
,
Evangelos Eleutherakis‐Papaiakovou
,
Magdalini Migkou
,
Vasiliki Spiliopoulou
,
Ilias Katsadouros
,
Stavroula Giannouli
,
Panagiotis Tsirigotis
,
Asimina Papanikolaou
,
Despina Fotiou
,
Konstantinos Giannakas
,
Erasmia Boutakoglou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2009
Diffuse MRI Marrow Pattern Correlates with Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly-Diagnosed Patients with Multiple Myeloma Treated with Novel Agents.
Lia A. Moulopoulos
,
Evangelos Terpos
,
Dimitrios Christoulas
,
Efstathios Kastritis
,
Dimitra Anagnostou
,
Ανδρέας Κουρέας
,
Μαρία Ρούσσου
,
Maria Gavriatopoulou
,
Magdalini Migkou
,
Marina Iakovaki
,
Μαρία Γκοτζαμανίδου
,
Vasilios Skiadas
,
Anna Tasidou
,
Meletios A Dimopoulos
Article
2025
Incidence and risk factors for infections in the real-world setting in newly diagnosed myeloma patients treated with modern induction regimens
Efstathios Kastritis
,
Eirini Solia
,
Foteini Theodorakakou
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Nikolaos Kanellias
,
Evangelos Eleutherakis Papaiakovou
,
Magdalini Migkou
,
Vasiliki Spiliopoulou
,
Ilias Katsadouros
,
Despina Fotiou
,
Stavroula Giannouli
,
Panagiotis Tsirigotis
,
Maria Gavriatopoulou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2011
Diffuse Pattern of Bone Marrow Involvement in MRI Is Associated with High Risk Cytogenetics and Poor Outcome in Newly Diagnosed, Symptomatic Patients with Multiple Myeloma,
Lia A. Moulopoulos
,
Efstathios Kastritis
,
Evangelos Terpos
,
Μαρία Γκοτζαμανίδου
,
Μαρία Ρούσσου
,
Ανδρέας Κουρέας
,
Magdalini Migkou
,
Maria Gavriatopoulou
,
Dimitra Gika
,
Vassilis Koutoulidis
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.